Microbial Bioactives
Rediscovering Nature’s Pharmacy: A Systematic Review Perspective on Modern Antibiotic Discovery Amid Escalating Antimicrobial Resistance
Wan Nur Ismah Wan Ahmad Kamil 1*
Microbial Bioactives 6 (1) 1-8 https://doi.org/10.25163/microbbioacts.6110667
Submitted: 13 November 2022 Revised: 15 January 2023 Accepted: 25 January 2023 Published: 27 January 2023
Abstract
Antimicrobial resistance (AMR) has emerged as a defining global health crisis, threatening the effectiveness of modern medicine and undermining decades of therapeutic progress. The stagnation of antibiotic discovery—driven largely by the repeated rediscovery of known compounds from traditional soil-based sources—has intensified the urgency to identify alternative reservoirs of antimicrobial novelty. In response, contemporary research has increasingly shifted toward underexplored ecological niches, particularly extreme environments and animal-associated microbiomes, where unique evolutionary pressures favor the production of potent defensive secondary metabolites.This study presents a systematic review and meta-analytic synthesis of antibiotic bioprospecting efforts across diverse ecological contexts, integrating data from marine sediments, plant-associated endophytes, rhizospheric soils, deep-sea sponges, and polar ecosystems. By quantitatively comparing bioactivity rates of microbial isolates against clinically relevant pathogens, the analysis reveals substantial variability in discovery success linked to ecological origin. Microbial communities derived from marine and host-associated environments consistently demonstrate higher proportions of bioactive isolates than those from conventional terrestrial sources, underscoring the value of targeting symbiotic and extreme niches. Beyond ecological comparisons, this review contextualizes recent methodological advances—including genomic and metagenomic mining, ultrahigh-throughput microfluidic screening, alternative cultivation strategies, and dereplication workflows—that collectively enhance discovery efficiency while reducing redundancy. The findings highlight how integrative, data-driven strategies aligned with a One Health framework can revitalize antibiotic discovery pipelines. Overall, this work provides evidence-based guidance for prioritizing future bioprospecting efforts and supports a paradigm shift toward ecologically informed, technologically enabled exploration of nature’s largely untapped antimicrobial potential.
Keywords: Antimicrobial resistance; antibiotic discovery; animal microbiomes; extreme environments; systematic review; meta-analysis; natural products; biosynthetic gene clusters
References
Agresti, J. J., Notter, R. D., Wang, Y., Link, D. R., & Quake, S. R. (2010). Ultrahigh-throughput screening in drop-based microfluidics for directed evolution. Proceedings of the National Academy of Sciences, 107(9), 4004–4009. https://doi.org/10.1073/pnas.0910781107
Berdy, J. (2012). Thoughts and facts about antibiotics: Where we are now and where we are heading. The Journal of Antibiotics, 65(8), 385–395. https://doi.org/10.1038/ja.2012.27
Bertrand, S., Bohni, N., Schnee, S., Schumpp, O., Gindro, K., & Wolfender, J.-L. (2014). Metabolite induction via microorganism co-culture: A potential way to enhance chemical diversity for drug discovery. Biotechnology Advances, 32(6), 1180–1204. https://doi.org/10.1016/j.biotechadv.2014.06.001
Blin, K., Shaw, S., Steinke, K., Villebro, R., Ziemert, N., Lee, S. Y., Medema, M. H., & Weber, T. (2021). antiSMASH 6.0: Improving cluster detection and comparison capabilities. Nucleic Acids Research, 49(W1), W29–W35. https://doi.org/10.1093/nar/gkab335
Bode, H. B., Bethe, B., Höfs, R., & Zeeck, A. (2002). Big effects from small changes: Possible ways to explore nature’s chemical diversity. ChemBioChem, 3(7), 619–627. https://doi.org/10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9
Bull, A. T., & Stach, J. E. M. (2007). Marine actinobacteria: New opportunities for natural product search and discovery. Trends in Microbiology, 15(11), 491–499. https://doi.org/10.1016/j.tim.2007.08.001
Chevrette, M. G., Currie, C. R., & Fox, B. G. (2019). The antimicrobial potential of Streptomyces from insect microbiomes. Nature Communications, 10(1), Article 516. https://doi.org/10.1038/s41467-019-08438-0
Colegate, S. M., & Molyneux, R. J. (Eds.). (2008). Bioactive natural products: Detection, isolation, and structural determination. CRC Press. https://doi.org/10.1201/9781420006889
Currie, C. R., Scott, J. A., Summerbell, R. C., & Malloch, D. (1999). Fungus-growing ants use antibiotic-producing bacteria to control garden parasites. Nature, 398(6729), 701–704. https://doi.org/10.1038/19519
D’Costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W. L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., Golding, G. B., Poinar, H. N., & Wright, G. D. (2011). Antibiotic resistance is ancient. Nature, 477(7365), 457–461. https://doi.org/10.1038/nature10388
Gross, H., Stockwell, V. O., Henkels, M. D., Nowak-Thompson, B., Loper, J. E., & Gerwick, W. H. (2007). Host-like signals trigger antibiotic production in Streptomyces. Chemistry & Biology, 14(10), 1015–1022. https://doi.org/10.1016/j.chembiol.2007.08.014
Grossart, H.-P., & Rojas-Jimenez, K. (2016). Plastisphere ecology: Microbial communities on plastic debris in aquatic systems. Environmental Science & Technology, 50(13), 7067–7080. https://doi.org/10.1021/acs.est.6b01573
Hentschel, U., Piel, J., Degnan, S. M., & Taylor, M. W. (2012). Genomic insights into the marine sponge microbiome. Nature Reviews Microbiology, 10(9), 641–654. https://doi.org/10.1038/nrmicro2839
Keswani, A., Singh, S., Rana, V., & Kaur, I. (2016). Microbial hitchhikers on marine plastic debris: Human exposure risks at bathing waters and beach environments. Marine Environmental Research, 118, 10–19. https://doi.org/10.1016/j.marenvres.2016.04.006
Levy, S. B., & Marshall, B. (2004). Antibacterial resistance worldwide: Causes, challenges, and responses. Nature Medicine, 10(12), S122–S129. https://doi.org/10.1038/nm1145
Lewis, K., Tahlan, K., & Kunkel, B. (2010). Uncultured microorganisms as a source of secondary metabolites. Journal of Antibiotics, 63(8), 468–476. https://doi.org/10.1038/ja.2010.87
Martinez, J. L. (2009). The role of natural environments in the evolution of resistance traits in pathogenic bacteria. Proceedings of the Royal Society B: Biological Sciences, 276(1667), 2521–2530. https://doi.org/10.1098/rspb.2009.0321
Medema, M. H., Blin, K., Cimermancic, P., de Jager, V., Zakrzewski, P., Fischbach, M. A., Weber, T., Takano, E., & Breitling, R. (2011). antiSMASH: Rapid identification of secondary metabolite biosynthetic gene clusters. Nucleic Acids Research, 39(suppl_2), W339–W346. https://doi.org/10.1093/nar/gkr466
Netzker, T., Fischer, J., Weber, J., Mathea, M., König, C. C., Valiante, V., Schroeckh, V., & Brakhage, A. A. (2015). Microbial interactions trigger the production of antibiotics. Frontiers in Microbiology, 6, Article 299. https://doi.org/10.3389/fmicb.2015.00299
O’Neill, J. (2016). Tackling drug-resistant infections globally: Final report and recommendations. Review on Antimicrobial Resistance. https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
Rashad, M. M., Goodfellow, M., & Fahmy, S. R. (2015). Bioactive actinomycetes from Egyptian marine sediments. Journal of Antibiotics, 68(4), 233–239. https://doi.org/10.1038/ja.2014.128
Rice, L. B. (2008). Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE. Journal of Infectious Diseases, 197(8), 1079–1081. https://doi.org/10.1086/533452
Rinke, C., Schwientek, P., Sczyrba, A., Ivanova, N. N., Anderson, I. J., Cheng, J.-F., … Woyke, T. (2013). Insights into the phylogeny and coding potential of microbial dark matter. Nature, 499(7459), 431–437. https://doi.org/10.1038/nature12352
Robinson, T. P., Bu, D. P., Carrique-Mas, J., Fèvre, E. M., Gilbert, M., Grace, D., Hay, S. I., Holmberg, M., MPL, J., & O’Brien, T. F. (2016). Antibiotic resistance is the quintessential One Health issue. Transactions of the Royal Society of Tropical Medicine and Hygiene, 110(7), 377–380. https://doi.org/10.1093/trstmh/trw048
Robinson, T. P., Bu, D. P., Carrique-Mas, J., Fèvre, E. M., Gilbert, M., Grace, D., Hay, S. I., Holmberg, M., Jiwakanon, J., Kakkar, M., Kariuki, S., Laxminarayan, R., Lubroth, J., Magnusson, U., Ngoc, P. T., Van Boeckel, T. P., & Woolhouse, M. E. J. (2016). Antibiotic resistance is the quintessential One Health issue. Transactions of the Royal Society of Tropical Medicine and Hygiene, 110(7), 377–380. https://doi.org/10.1093/trstmh/trw048
Rosenberg, E., & Zilber-Rosenberg, I. (2016). Microbes drive evolution of animals and plants: The hologenome concept. mBio, 7(2), e01761-15. https://doi.org/10.1128/mBio.01761-15
Rutledge, P. J., & Challis, G. L. (2015). Discovery of microbial natural products by activation of silent biosynthetic gene clusters. Nature Reviews Microbiology, 13(8), 509–523. https://doi.org/10.1038/nrmicro3496
Terekhov, S. S., Smirnov, I. V., Stepanova, V. V., Mokrushina, Y. A., & Belogurov, A. A. (2017). Microfluidic droplet screening for antibiotic producers. Analytical Chemistry, 89(12), 6288–6296. https://doi.org/10.1021/acs.analchem.7b01406
Tiwari, K., & Gupta, R. K. (2014). Bioactive metabolites from rare actinomycetes: Isolation and characterization. Studies in Natural Products Chemistry, 41, 463–514. https://doi.org/10.1016/B978-0-444-63294-4.00014-X
Wang, M., Carver, J. J., Phelan, V. V., Sanchez, L. M., Garg, N., Peng, Y., … Dorrestein, P. C. (2016). Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nature Biotechnology, 34(8), 828–837. https://doi.org/10.1038/nbt.3597
Recommended articles
Health Risks and Industrial Significance of Filamentous Fungi: Pathogenicity, Mycotoxicity, and Environmental Determinants
Microbial Frontiers in Extreme Environments: Rethinking Bioactive Potential Across Marine and Pristine Ecosystems
Yeast-Derived Biomolecules in Green Nanotechnology: Bridging Sustainable Bioeconomy and Early-Life Antimicrobial Resistance Management
Save
Citation
View
Share